Clinical Trials Directory

Trials / Completed

CompletedNCT03529058

Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

Evaluation of Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

Status
Completed
Phase
Study type
Observational
Enrollment
193 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Retrospective study in the 3 intensive care units of the Brest Teaching Hospital (France) during a 18-months period (June 2014 -December 2015) to study the independent association between hypophosphatemia and 90-day mortality.

Conditions

Timeline

Start date
2017-11-26
Primary completion
2018-03-31
Completion
2018-03-31
First posted
2018-05-18
Last updated
2018-05-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03529058. Inclusion in this directory is not an endorsement.

Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU (NCT03529058) · Clinical Trials Directory